Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Tables)

v3.24.1.1.u2
Net loss per share (Tables)
3 Months Ended
Mar. 31, 2024
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three-month periods ended presented below:

   
March 31,
 
   
2024
   
2023
 
Series A and RDO warrants
   
7,204,299
     
7,204,299
 
Stock options
   
4,827,433
     
3,601,427
 
RSUs     993,112       291,584  
Former Rexahn warrants
   
     
60,713